Tirzepatide Helps Adults With Obesity Without Diabetes Lose 15% to 21% of Their Body Weight Over 72 Weeks

Am Fam Physician. 2023 Jan;107(1):99.
No abstract available

MeSH terms

  • Adult
  • Body Weight
  • Diabetes Mellitus*
  • Diabetes Mellitus, Type 2*
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents
  • Obesity
  • Tirzepatide

Substances

  • Tirzepatide
  • Gastric Inhibitory Polypeptide
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor